← Back to Search

Radiation Therapy

IMRT for Brain Cancer

N/A
Waitlist Available
Led By Ben Liem, MD
Research Sponsored by New Mexico Cancer Care Alliance
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Karnofsky performance status ≥ 70
Age ≥ 18 years
Must not have
Patients with leptomeningeal metastases
Prior radiation therapy to the brain besides radiosurgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post-treatment
Awards & highlights
No Placebo-Only Group

Summary

"This trial is comparing a newer type of radiation therapy called intensity modulated radiation therapy (IMRT) to the standard whole brain radiation therapy for treating brain metastases. The study aims to see if IM

Who is the study for?
This trial is for adults over 18 with a performance status indicating they can care for themselves and are not bedridden. They must understand the study, consent to it, use birth control if of childbearing potential, and have a negative pregnancy test. Participants should have multiple brain metastases from solid tumors (excluding small cell lung cancer and germ cell malignancy) diagnosed within the last five years.
What is being tested?
The trial tests Intensity Modulated Radiotherapy (IMRT) as an alternative to standard whole brain radiation for patients with brain metastases from primary cancers. It aims to see if IMRT better controls visible tumors while reducing side effects like hair loss and improving quality of life.
What are the potential side effects?
While specific side effects aren't listed here, typical ones associated with radiotherapy include fatigue, headaches, scalp irritation leading to hair loss, memory problems, difficulty thinking or concentrating ('brain fog'), skin changes in treated area.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am able to care for myself but may not be able to do active work.
Select...
I am 18 years old or older.
Select...
I have more than one brain tumor identified by a doctor.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have cancer that has spread to the lining of my brain and spinal cord.
Select...
I have had brain radiation therapy other than radiosurgery.
Select...
My cancer has spread to my brainstem or the area where my optic nerves cross.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Heart rate
Secondary study objectives
Change in memory
Rate of permanent alopecia

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intensity Modulated Radiotherapy (IMRT)Experimental Treatment1 Intervention
Radiation therapy to a dose of 60 Gray (Gy)/45 Gy to gross disease and 30 Gy to subclinical sites, delivered over 15 fractions

Find a Location

Who is running the clinical trial?

New Mexico Cancer Care AllianceLead Sponsor
70 Previous Clinical Trials
52,430 Total Patients Enrolled
New Mexico Cancer Research AllianceLead Sponsor
70 Previous Clinical Trials
52,430 Total Patients Enrolled
Ben Liem, MDPrincipal InvestigatorUniversity of New Mexico Comprehensive Cancer Center
1 Previous Clinical Trials
2 Total Patients Enrolled
~2 spots leftby Oct 2025